0121-0319
0121-0319
S0121-03192020000100031
10.18273/revmed.v33n1-2020004
Colombia
00
04
2020
00
04
2020
33
1
31
38
[
2015
]
[
TEVA, Pharmaceuticals Inc
2015
]
[
2018
42
353-9
]
[
2010
106
173-80
]
[
2017
I
23
23
]
[
2013
]
[
CONACE
2009
]
[
2003
42
123-37
]
[
2009
301
1148-54
]
[
2014
231
3217-28
]
[
2006
67
554-66
]
[
2008
33
1477-502
]
[
2009
6
]
[
2005
116
777-84
]
[
2007
3
595-602
]
[
2009
47
153-6
]
[
2009
2
39-43
]
[
2015
52
99-101
]
[
2013
53
662-4
]
[
2012
3
513-7
]
[
2011
6
1-11
]
[
2014
34
738-41
]
[
2005
45
612-8
]
[
2019
34
]
[
2018
27
1-9
]
[
2018
58
152-7
]
[
2000
20
8620-8
]
[
2004
27
19-25
]
[
2007
104
12554-9
]
[
2006
317
882-9
]
[
2009
301
1148-54
]
[
2013
4
139
]
[
2017
45
167-74
]
[
2015
4
235958
]
[
D'avila L.Vey L.Barcelos R.Burger M
2019
92
199-206
]
[
2015
9
215
]
[
2015
15
6166
]
[
2017
31
243-9
]
[
2003
165
260-9
]
[
2017
9
1-9
]
[
2011
36
950-9
]
[
2019
130
1488-98
]
[
2013
64
490-5
]
[
2014
24
529-39
]
[
2010
62
187-206
]
[
2017
47
2358-68
]
[
2015
25
1865-81
]
[
2019
10
333
]
[
2017
2
115-22
]
[
2016
63
488-96
]